Skip to content

Clinical trials

Hypertension trials in Bulgaria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Country / region: Bulgaria Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20072
20082
20092
20113
20151
20172
20184
20193
20201
20211
20225
20235
20243
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Active, not recruiting4
Recruiting4
Unknown status3
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Boehringer Ingelheim5
Medical University of Sofia3
Takeda3
Corcept Therapeutics2
Mineralys Therapeutics Inc.2
Novartis Pharmaceuticals2
United Therapeutics2
Abbott1
Alnylam Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension40
Renal Insufficiency, Chronic7
Cardiovascular Diseases6
Diabetes Mellitus, Type 25
Heart Failure5
Diabetes Mellitus4
Essential Hypertension4
Atrial Fibrillation3
Stroke3
Vascular Diseases3

Trials

Showing 26 to 40 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.